MedPath
FDA Approval

INFASURF

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Company
ONY Biotech Inc.
DUNS: 622369833
Effective Date
September 26, 2023
Labeling Type
HUMAN PRESCRIPTION DRUG LABEL
Calfactant(35.7 mg in 1 mL)

Registrants1

Companies and organizations registered with the FDA for this drug approval, including their contact information and regulatory details.

ONY Biotech Inc.

622369833

Manufacturing Establishments1

FDA-registered manufacturing facilities and establishments involved in the production, packaging, or distribution of this drug product.

ONY Biotech Inc.

ONY Biotech Inc.

ONY Biotech Inc.

622369833

Products1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

INFASURF

Product Details

NDC Product Code
61938-456
Application Number
BLA020521
Marketing Category
BLA (C73585)
Route of Administration
ENDOTRACHEAL
Effective Date
September 26, 2023
SODIUM CHLORIDEInactive
Code: 451W47IQ8XClass: IACT
Code: Q4K217VGA9Class: ACTIBQuantity: 35.7 mg in 1 mL
© Copyright 2025. All Rights Reserved by MedPath